European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2008
Role of the genetic study in the management of carotid body tumor in paraganglioma syndrome.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Antonello M, Piazza M, Menegolo M, Opocher G, Deriu G P, Grego F
Аннотация
Diagnosis of carotid body tumor (CBT) was made in a 36 years old woman. The pre-operative examination included genetic analysis of the succinate dehydrogenase that showed a mutation in his subunit D responsible of multiple paraganglioma at slow growth. Subsequently a thoraco-abdominal CT and indium(111) octreotide body scan were performed and another paraganglioma was detected in the anterior mediastinum. CBT was surgically removed; differently the thoracic lesion due to his benign genetic profile was not treated. During a 3-years follow-up the thoracic paraganglioma as expected, didn't increase. Genetic analysis of succinate dehydrogenase, should be performed in the management of CBT.
Предметные рубрики MeSH
AdultCardiac Surgical ProceduresCarotid Body TumorDNA Mutational AnalysisFemaleGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansMagnetic Resonance AngiographyMediastinal NeoplasmsPolymorphism, Single NucleotideSuccinate DehydrogenaseSyndromeTomography, X-Ray ComputedTreatment Outcome